Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 4/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 1.00 |
| ▸ | LMNA | P02545 | 5/20 | 0.69 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.69 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.64 |
| ▸ | MEN1 | O00255 | 4/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.64 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.64 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.64 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | HPGD | P15428 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | NPY1R | P25929 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Mephenesin SCHEMBL6482337 | 1.00 | CYP1A2 (1.00) | CYP1A2KDM4ELMNAAGTR1ALOX15 | |
| Mephenesin SCHEMBL29379669 | 1.00 | CYP1A2 (1.00) | CYP1A2KDM4ELMNAAGTR1ALOX15 | |
| Mephenesin SCHEMBL332864 | 1.00 | CYP1A2 (1.00) | CYP1A2KDM4ELMNAAGTR1ALOX15 | |
| Mephenesin SCHEMBL6830756 | 0.96 | CYP1A2 (0.93) | CYP1A2KDM4ELMNAAGTR1ALOX15 | |
| Mephenesin SCHEMBL8829925 | 0.92 | CYP1A2 (0.84) | CYP1A2KDM4ELMNAAGTR1ALOX15 | |
| SCHEMBL18423672 | 0.90 | KDM4E (0.82) | CYP1A2KDM4ELMNAAGTR1ALOX15 | |
| Mephenesin SCHEMBL11403767 | 0.88 | CYP1A2 (0.77) | CYP1A2KDM4ELMNAAGTR1ALOX15 | |
| SCHEMBL13328792 | 0.87 | CYP1A2 (0.77) | CYP1A2KDM4ELMNAAGTR1ALOX15 | |
| Mephenesin SCHEMBL28316204 | 0.87 | CYP1A2 (0.75) | CYP1A2KDM4ELMNAAGTR1ALOX15 | |
| SCHEMBL26326254 | 0.86 | CYP1A2 (0.81) | CYP1A2KDM4ELMNAAGTR1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3282 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4702396-A1 | SPECTACLE LENS FOR MANAGING MYOPIA BY MEANS OF A DUAL PROGRESSION CONTROL PROCESS | Rodenstock GmbH (DE) | 2026-03-04 | — | — | EP | claimed |
| US-20250313900-A1 | COMPOSITIONS AND THERAPEUTIC AGENTS FOR MODULATING INFLAMMATORY RESPONSES ON BOTH TUMOR AND IMMUNE CELLS | THE METHODIST HOSPITAL | 2025-10-09 | — | — | US | claimed |
| EP-4623932-A1 | AGENT FOR ALLEVIATING CLOZAPINE-INDUCED SIALORRHEA | National University Corporation Chiba University (JP) | 2025-10-01 | — | — | EP | claimed |
| EP-4587883-A1 | REDUCING THE PROGRESSION OF MYOPIA BY MEANS OF AN ADAPTED ACTIVE REGION | Rodenstock GmbH (DE) | 2025-07-23 | — | — | EP | claimed |
| CN-119998352-A | Epoxy resin curing agent, epoxy resin composition, sealing material, electrically conductive material, thermally conductive material, adhesive for camera module, adhesive for structure, matrix resin for fiber-reinforced plastic, impregnating and fixing material, interlayer insulating film, film-type solder resist, sealing sheet, electrically conductive film, anisotropic electrically conductive film, thermally conductive film, and method for producing dyed cured product | 旭化成株式会社 | 2025-05-13 | — | — | CN | claimed |
| US-20250149116-A1 | ABL1 FUSIONS AND USES THEREOF | FOUNDATION MEDICINE, INC. (US) | 2025-05-08 | — | — | US | claimed |
| CN-119521616-A | Energy-saving temperature and humidity regulating air conditioner and regulating method | 浙江大观自动化科技有限公司 | 2025-02-25 | — | — | CN | claimed |
| WO-2024223632-A1 | REDUCING THE PROGRESSION OF MYOPIA BY MEANS OF AN ADAPTED ACTIVE REGION | RODENSTOCK GMBH (DE) | 2024-10-31 | — | — | WO | claimed |
| WO-2024223645-A1 | SPECTACLE LENS FOR MANAGING MYOPIA BY MEANS OF A DUAL PROGRESSION CONTROL PROCESS | RODENSTOCK GMBH (DE) | 2024-10-31 | — | — | WO | claimed |
| WO-2024163952-A2 | IDENTIFICATION OF NOVEL SAFE HARBOR SITES FOR THE STABLE EXPRESSION OF FUSOGEN LENTIVIRAL VECTOR | SANA BIOTECHNOLOGY, INC. (US) | 2024-08-08 | — | — | WO | claimed |
| EP-0341745-B1 | Crosslinked carboxy polysaccharides | FIDIA SPA (IT) | 1994-12-14 | — | — | EP | claimed |
| EP-0220030-B1 | ORAL DELIVERY SYSTEM | BIOTECHNOLOGY AUSTRALIA PTY. LTD. (AU) | 1991-06-19 | — | — | EP | claimed |
| EP-0122151-B1 | PRODUCTION OF PRIMARY OR SECONDARY ALCOHOL DERIVATIVES OF PHOSPHOLIPIDS BY THE ENZYMATIC TECHNIQUE | MEITO SANGYO KABUSHIKI KAISHA (JP) | 1989-02-15 | — | — | EP | claimed |
| US-4783402-A | Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique | MEITO SANGYO KABUSHIKI KAISHA (JP) | 1988-11-08 | — | — | US | claimed |
| US-4722938-A | COMBINED WITH NON-STEROIDAL ANTIINFLAMMATORY DRUG | ANALGESIC ASSOCIATES (US) | 1988-02-02 | — | — | US | claimed |
| EP-0220030-A2 | Oral delivery system | BIOTECHNOLOGY AUSTRALIA PTY. LTD. (AU) | 1987-04-29 | — | — | EP | claimed |
| WO-1987002251-A1 | ORAL DELIVERY OF BIOLOGICALLY ACTIVE SUBSTANCES BOUND TO VITAMIN B12, OR ANALOGUES THEREOF | BIOTECHNOLOGY AUSTRALIA PTY. LTD. (AU) | 1987-04-23 | — | — | WO | claimed |
| EP-0205492-A1 | ANALGESIC, ANTI-INFLAMMATORY AND SKELETAL MUSCLE RELAXANT COMPOSITIONS | SUNSHINE, Abraham (US) | 1986-12-30 | — | — | EP | claimed |
| WO-1986003681-A1 | ANALGESIC, ANTI-INFLAMMATORY AND SKELETAL MUSCLE RELAXANT COMPOSITIONS | SUNSHINE ABRAHAM | 1986-07-03 | — | — | WO | claimed |
| EP-0122151-A2 | Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique | MEITO SANGYO KABUSHIKI KAISHA (JP) | 1984-10-17 | — | — | EP | claimed |